MCCARTHY SEAN A. (President and CEO) sold 9.9% of their position (118.97K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $764.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2026ACC: 0001610717-26-000124
DirectorOfficer· President and CEO
Since Jul 2018
-118.97K
Net shares
Net seller
$764.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
118.97K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−118.97K
Price / share
$6.42
Trade value
$764.14K
% of position
9.9%
3/17/2026
1.20M→1.08M
Total
Net shares
−118.97K
Net value
-$764.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −118.97K | $6.42 | $764.14K | 9.9% | 1.20M | 1.08M |
| Total | −118.97K | -$764.14K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported